International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: http://www.sciepub.com/journal/ijcd Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
Go
International Journal of Celiac Disease. 2020, 8(3), 110-116
DOI: 10.12691/ijcd-8-3-8
Open AccessReview Article

A Systematic Review on Use of Liver Function Tests to Assess Association between Liver Injury and COVID 19 Disease

Richard Chinaza IKEAGWULONU1, Nkereuwem Sunday ETUKUDOH2, Mark Uchejeso OBETA3, , Henry Chukwuemeka URO-CHUKWU4 and ImohEtim IBANGA5

1Department of Chemical Pathology, Alex Ekwueme Federal University Teaching Hospital, Abakaliki-Nigeria

2Department of Haematology, Federal School of Medical Laboratory Science, Jos, Nigeria

3Department of Medical Laboratory Management, Federal School of Medical Laboratory Science, Jos, Nigeria

4Department of Community Medicine, College of Health Science, Ebonyi State University, Abakaliki, Ebonyi State, Nigeria

5Department of Chemical Pathology, Federal School of Medical Laboratory Science, Jos, Nigeria

Pub. Date: August 02, 2020

Cite this paper:
Richard Chinaza IKEAGWULONU, Nkereuwem Sunday ETUKUDOH, Mark Uchejeso OBETA, Henry Chukwuemeka URO-CHUKWU and ImohEtim IBANGA. A Systematic Review on Use of Liver Function Tests to Assess Association between Liver Injury and COVID 19 Disease. International Journal of Celiac Disease. 2020; 8(3):110-116. doi: 10.12691/ijcd-8-3-8

Abstract

BACKGROUND: As at 27th of June 2020, the COVID 19 pandemic had affected 9,653,048 people across the world including 491,128 deaths. We reviewed different studies on liver function tests in COVID 19 patients to better understand how the liver injury is associated with COVID 19 disease. METHODS: A review of the literature was carried out between18th May and 10thJune 2020 on the studies that investigated liver function tests in COVID 19 patients as a marker of liver injury in the patients. The databases used were Pubmed/Medline, Google Scholar and JSTOR and the search protocol involves a combination of words like laboratory diagnosis, liver function tests and COVID 19, SARS-COV-2 and coronavirus. RESULT: Twelve relevant articles were identified out of a total of 212 articles that were initially identified after duplicates were removed. The twelve articles reviewed comprise of 1,926 COVID 19 infected patients representing 1,003(52.1%) males and 923(47.9%) females. Comparing mild to severe cases of COVID 19, the most prevalent laboratory findings were increased AST (100%), ALT (91.7%) and total bilirubin (71.4%), as well as 100%, decreased serum level of albumin. CONCLUSION: Liver injury is associated with COVID 19 as evident with observed changes in serum levels of liver enzymes, bilirubin and albumin in these individuals.

Keywords:
SARS-CoV-2 COVID-19 medical laboratory diagnosis liver function tests

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  World health organization 2020. WHO Coronavirus disease (COVID 19) outbreak. 2020. Available from https://www.who.int/health topics/coronavirus#tab=tab_1.
 
[2]  WHO Emerging respiratory viruses, including COVID-19: methods for detection, prevention, response and control. Available from https://openwho.org/courses/introduction-to-ncov . Accessed 28th June 2020.
 
[3]  WHO Coronavirus Disease (COVID-19) Dashboard. Available from https://covid19.who.int/?gclid=Cj0KCQjw3N.v3BRC8ARIsAPh8 hgLgwA6Dip5mUrQHwoAs3eeyCyex9FqAFQai05STszLr26QSf wTVL. pkaAj54EALw_wcB. Accessed 27 June 2020.
 
[4]  Nigerian Center for Disease Control (NCDC) 2020. COVID-19 Nigeria. Available at https://covid19.ncdc.gov.ng/. Accessed 27June 2020.
 
[5]  Huang Y, Wang X, Li L, Ren J, Zhao Y, Hu, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (10223) (2020): 497-506.
 
[6]  Ronco C.and Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020: 1-3.
 
[7]  Feng G,Zheng K.I,Yan Q.Q, Rios R.S,Targher G, Byrne C.D, Poucke S.V, Wen-Yue Liu W.Y, and Zheng M.H.COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies.J ClinTranslHepatol. 2020 Mar 28; 8(1): 18-24.
 
[8]  Aygun H. Vitamin D Can Prevent COVID-19 Infection-Induced Multiple Organ Damage. NaunynSchmiedebergs Arch Pharmacol 2020; 393(7): 1157-1160.
 
[9]  Ikeagwulonu R.C, Etukudoh N.S, Obeta M.U, Mgbecheta C.U. Does Vitamin D Serum Levels Affect The Risk of Covid 19 and its Clinical Outcomes? A Review of Literature. EAS J Med Surg 2020; 2(6).
 
[10]  Zeng F, Huang Y, Guo Y, Chen X, Xiao L, Deng G. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. International Journal of Infectious Diseases. 2020; 96: 467-474.
 
[11]  Rothan H.A, Byrareddy S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity 2020; 109.
 
[12]  Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, Xiong Y, Cheng Z, Gao S, Liang K, Luo M, Chen T, Song S, Ma Z, Chen X, Zheng R, Cao Q, Wang F, Zhang Y. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China .Clinical Infectious Diseases.
 
[13]  Liu W; Tao Z.W, Wang L, Yuan M.L, Liu K, Zhou L, Wei S, Deng Yan, Liu J, Liu H.G, Yang M, Hu Y.Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese Medical Journal; 2020 (133(9): 1032-1038.
 
[14]  Sun Y, Dong Y, Wang L,Xie H, Li B,Chang C, Wang F. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. Journal of Autoimmunity.
 
[15]  Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020; 272.
 
[16]  Cai Q, Huang D, Ou P, Yu H, Zhu Z, Xia Z, Su Y, Ma Z, Zhang Y, Li Z, He Q, Liu L, Fu Y, Chen J. COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy; 2020; 00: 1-11.
 
[17]  Wang F, Yang Y, Dong K, Yan Y, Zhang S, Ren H, Yu X, Shi X. Clinical characteristics of 28 patients with diabetes and covid-19 in wuhan, china.Endocr Pract.2020; 26.
 
[18]  Huang J, Cheng A, Kumar R, Fang Y, Chen G, Zhu Y, Lin S. Hypoalbuminemia predicts the outcome of COVID‐19 independent of age and co‐morbidity. Journal of Medical Virology; 2020.
 
[19]  Chen G,Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, Song J, Chen T, Han M,Li S, Luo X, Zhao J, and Ning Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5): 2620-2629.
 
[20]  Zhang X, Cai H, Hu J, Lian J, Gu J, Zhang S, Ye C, Lu Y, Jin C, Yu G, Jia H, Zhang Y, Sheng J, Li L, Yang Y. Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings. International Journal of Infectious Diseases, 2020; 94: 81-87.
 
[21]  Chen W, Zheng K.I,Liu S,Yan Z, Xu C, and Qiao Z. Plasma CRP level is positively associated with the severity of COVID-19. Ann ClinMicrobiolAntimicrob 2020; 19: 18.
 
[22]  Israelsen S.B, Kristiansen K.T, Hindsberger B, Ulrik C.S, Andersen O, Jensen M, Andersen S, Rasmussen C, Jørgensen H.L, Østergaard C, Lindhardt B. Ø, Kronborg G, & Benfield T.Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020. Dan Med J 2020; 67(6): A05200313.
 
[23]  Zhang J, Liu P, Wang M, Wang J, Chen J, Yuan W, Li M, Xie Z, Dong W, Li H, Zhao Y, Wan L, Chu T, Wang L, Zhang H, Tao T, Ma J. The clinical data from 19 critically ill patients with coronavirus disease 2019: a single-centered, retrospective, observational study. Journal of Public Health (Berl.): From Theory to Practice.
 
[24]  Parohan M, Yaghoubi S, and Sera A. Liver injury is associated with severe coronavirus disease2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies. Hepatology Research 2020.
 
[25]  Tian S, Liu H, Liao M, Wu Y, Yang C, Cai Y, Peng Z, and Xiao S.Y. Analysis of Mortality in Patients With COVID-19: Clinical and Laboratory Parameters.Open Forum Infect Dis. 2020; 7(5): 152.
 
[26]  Saad M, Omrani AS, Baig K et al. Clinical aspects and out-comes of 70 patients with Middle East respiratory syndromecoronavirus infection: a single-center experience in SaudiArabia.Int J Infect Dis2014; 29: 301-6.35
 
[27]  Al-Hameed F, Wahla AS, Siddiqui S et al. Characteristics andoutcomes of Middle East respiratory syndrome coronaviruspatients admitted to an intensive care unit in Jeddah, SaudiArabia.J Intensive Care Med. 2016; 31: 344-8.
 
[28]  McLernon DJ, Donnan PT, Sullivan FM, et al. Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts. BMJ Open 2014; 4: e004837.
 
[29]  Ahmed Z, Ahmed U, Walayat S, Ren J, Martin D.K, Moole H, Koppe S, Yong S, and Dhillon S. Liver function tests in identifying patients with liver disease.ClinExpGastroenterol. 2018; 11: 301-307.
 
[30]  Vishal Sanklecha, Novel Coronavirus COVID-19 and Its Diagnosis and Treatments.International Journal of Celiac Disease, vol. 8, no. 1 (2020): 39-43.
 
[31]  Etukudoh NS, Ejinaka RO, Olowu FA, Obeta MU, Adebowale OM, Udoudoh M P. Coronavirus (COVID-19); Review from ANigerian Perspective. 2020-9(1). AJBSR.MS.ID.001347.
 
[32]  Obeta M. Uchejeso, Ejinaka R. Obiorah, Ofor I. Bassey, Ikeagwulonu R. Chinaza, AgboEjiofor C., and AbaraUkeme S, “Nigerian COVID-19 (Coronavirus) Patients Update, the Realities with MedicalLaboratory Diagnostic Sites.” American Journal of Epidemiology and Infectious Disease, vol. 8, no. 1 (2020): 13-15.